EARLY EXERCISE DETECTION FOR DIABETES MANAGEMENT

    公开(公告)号:US20210313037A1

    公开(公告)日:2021-10-07

    申请号:US16840603

    申请日:2020-04-06

    Abstract: A system, techniques, and computer-readable media includes examples that provide an indication of an early exercise detection are described. An example of an early exercise detection application executed by a processor may cause the processor to perform functions and be operable to obtain image data including metadata from a camera of a mobile device during, for example, an unlock procedure of a mobile device. The processor may determine whether the obtained image data includes location or timestamp information in metadata or has image data that may be recognized as exercise-related objects. Based on the determinations, the processor may output an indication of early exercise detection to an artificial pancreas application, which is operable to adjust an amount of insulin to be delivered to a user.

    DRUG DELIVERY SYSTEM WITH SENSOR HAVING OPTIMIZED COMMUNICATION AND INFUSION SITE

    公开(公告)号:US20200069875A1

    公开(公告)日:2020-03-05

    申请号:US16116071

    申请日:2018-08-29

    Abstract: A drug delivery system having a drug delivery device and an associated sensor is provided. The sensor can be associated with a sensing site on user. The drug delivery device can be positioned over the sensor in any rotational position and can be associated with an infusion site on the user. The close positioning of the sensor and the drug delivery device allows data from the sensor to be relayed to the drug delivery device and then on to a remote control device. Further, the drug delivery device can be replaced at the end of its duration of use, which is shorter than the duration of use of the sensor, without disturbing the sensor. Subsequent drug delivery devices can then be used with the sensor while allowing each corresponding infusion site to be changed, thereby providing more efficient operation of the drug delivery system.

    SEMI-RIGID AND FLEXIBLE ELEMENTS FOR WEARABLE DRUG DELIVERY DEVICE RESERVOIR

    公开(公告)号:US20200023119A1

    公开(公告)日:2020-01-23

    申请号:US16514621

    申请日:2019-07-17

    Abstract: Disclosed are examples of reservoir and reservoir systems usable with a wearable drug delivery device. An example reservoir may include a flexible component coupled to a shell component. The shell component may include drainage channels to facilitate extraction of the liquid drug from the reservoir. A reservoir system example may include an exoskeleton configured around a flexible reservoir to guide the expansion and collapse of the flexible reservoir. Alternatively, one or more rigid panels may be coupled to corresponding flat surfaces of the flexible reservoir to guide the expansion and collapse of the flexible reservoir. A further reservoir example may include a flexible thin film reservoir having peel-able restraints configured to seal off corresponding sections of the reservoir, sequentially break, enabling the liquid drug to sequentially fill corresponding sections in a controlled and predicable manner. A wearable drug delivery device example suitable for utilizing the described examples is provided.

    CARTRIDGE HOLD-UP VOLUME REDUCTION
    16.
    发明申请

    公开(公告)号:US20180200444A1

    公开(公告)日:2018-07-19

    申请号:US15875115

    申请日:2018-01-19

    Abstract: Drug delivery systems with reduced hold-up volumes are provided. The drug delivery systems include a cartridge configured to hold a liquid drug. A cartridge stopper is positioned in a first portion of the cartridge. A needle guide component is positioned within the cartridge stopper. A needle is positioned within a central opening of the needle guide. A plunger is positioned in a second portion of the cartridge. The plunger includes a fluid path pocket facing and aligned with the central opening of the needle guide component. The plunger is driven toward the cartridge stopper to expel the liquid drug from the cartridge through the needle. An end of the needle can be positioned within the fluid path pocket when the plunger is pushed against the cartridge stopper, ensuring that only a small volume of the liquid drug remains in the cartridge when delivery of the liquid drug is completed.

    LOW FORCE VALVES FOR DRUG DELIVERY PUMPS
    17.
    发明公开

    公开(公告)号:US20230332694A1

    公开(公告)日:2023-10-19

    申请号:US18338411

    申请日:2023-06-21

    Abstract: Disclosed are examples of valve systems and methods of operating the respective valve systems. An example valve system may include a valve body, an inlet component, an outlet component and a valve tube. The valve body may include a first void and a second void. The inlet component may be coupled to the first void and the outlet component may be coupled to the second void. The valve tube may include a side port and may be positioned through the valve body and coupled to the first void, the inlet component, the second void, and the outlet component. Other valve system examples may include including a valve body, a first septum, a second septum, a first piston, a second piston and a tube. The disclosed methods describe the interaction of the respective components of the respective valve system example.

    METHODS AND SYSTEMS FOR MANAGING FLUID PUMP DELIVERY IMPEDIMENTS

    公开(公告)号:US20230061740A1

    公开(公告)日:2023-03-02

    申请号:US17822002

    申请日:2022-08-24

    Abstract: Fluid delivery devices with occlusion management are described. For example, a fluid delivery system may include at least one force element, at least one moveable element configured to be moved in a dispensing direction by the at least one force element during a pump cycle to expel a fluid from the fluid delivery system, and an occlusion management system comprising at least one emergency element operably coupled to the at least one moveable element, the occlusion management system comprising logic operative to activate the at least one emergency element responsive to a determination of an occlusion to provide additional force to move the at least one moveable element in the dispensing direction. Other embodiments are described.

Patent Agency Ranking